• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy Hold FDA accountable for placing abortion advocacy above women’s health
Economy

Hold FDA accountable for placing abortion advocacy above women’s health

by March 15, 2024
by March 15, 2024 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

I’ll never forget the day that I spoke to Monty, the father of a young woman, Holly, who had died as the result of chemical abortion at the age of 18. She had graduated from high school a few months earlier and went to a local Planned Parenthood for the abortion drugs. 

She died of septic shock a few weeks later. 

Monty, a man who identified as being ‘pro-choice,’ told me that he wanted to do everything possible to teach people about the dangers of chemical abortion.

The sad reality is that chemical abortions – or abortion drugs – are much harder on women’s health and present many health complications. In fact, the Food and Drug Administration’s label for abortion drugs warns that roughly one in 25 women taking the drugs will end up in the emergency room.

Soon oral arguments will happen at the Supreme Court in the case FDA v. Alliance for Hippocratic Medicine, in which the court will examine whether the Food and Drug Administration has failed to do the very job it was created for, to protect the public’s health by ensuring the safety and efficacy of drugs. 

I would argue that the FDA is doing a profound disservice to women and girls everywhere in the name of abortion.

In 2000, when the FDA first approved the use of abortion drugs – the combined regimen of mifepristone and misoprostol – to terminate a pregnancy, they instituted safety standards in light of inherent risks associated with chemical abortions. 

It was required that women be seen by a doctor when taking abortion drugs and that they be seen prior to and cared for during the process. This was crucial to protect the safety of the woman taking these drugs. 

Additionally, prescribers were required to report all serious complications (adverse events) that arose to the FDA, which were then made public through a website.

Inexplicably, in 2016, the FDA removed most of these safety standards, reducing the number of in-person doctor visits for a woman seeking a chemical abortion from three to one, removing all prescriber reporting requirements except in the case of death, and extending the period of time in which it is ‘safe’ for a woman to take the drug from seven to 10 weeks, putting women and young girls at greater risk.

Even worse, in 2021, the FDA completely eliminated the in-person dispensing requirement for mifepristone, allowing the drug to be obtained through the mail without ever seeing a medical professional in-person.

Abortion drugs distributed via mail, over state lines and across borders, have created additional hazards for women seeking them. Effectively, all meaningful safety measures were eliminated, leaving women in grave risk of complications.

For example, consider that without having an in-person doctor visit, a woman will not confirm the true gestational age of her unborn child or whether she has a dangerous ectopic pregnancy. 

If a woman were to have an undiagnosed ectopic pregnancy and then take the abortion drugs, she will very likely face extreme health complications or even loss of life because the typical adverse reactions to abortion drugs resemble those of a life-threatening ruptured ectopic pregnancy.

According to the FDA’s limited data collection, since the drug was approved in 2000, 4,218 women experienced adverse effects of the drug, 1,049 were hospitalized, 604 experienced severe blood loss, and 418 have had infections.

Tragically, as many as 32 women that we know of have died after such complications from the abortion drug. 

Alyona Dixon tragically lost her life after taking the abortion drugs. She contracted sepsis after the abortion. The infection was left undiagnosed and ultimately took her life. Her husband lost his wife and her son lost his mother. This likely would have been prevented – her life likely would have been saved – if appropriate safety regulations were in place.

Abortion drugs also often carry a heartbreakingly heftier emotional toll, as the woman becomes the abortionist, ingesting the pills, and often tragically sees her baby pass. The sad reality is that many women face mental health repercussions in the months and years after an abortion. 

Numerous studies have shown that women who have abortions show higher rates of depression, anxiety, PTSD and substance abuse. My heart breaks for any woman who goes through this scenario. At the March for Life, we try to always emphasize that there can be hope and healing after abortion.

Women and girls deserve so much better than the grave risks they are now exposed to with the negligent elimination of critical FDA safeguards around abortion drugs. They should have access to ongoing in-person care from a licensed doctor when taking these drugs. They deserve protection, care, guidance and, above all else, love and support.

My hope is that the court will hold the FDA accountable for placing abortion advocacy above women’s health and reinstate commonsense standards and protections surrounding the distribution of abortion drugs.

For women like Holly or Alyona, such standards in place could have meant the difference between life or death. Until that happens, we at the March for Life will continue our work so that no woman believes chemical abortion is her only option, and instead knows that the pro-life movement is here to support and protect every woman and every child.

This post appeared first on FOX NEWS
You Might Also Like
  • Biden admin hires czar to monitor school book ban: ‘Threat’ to students
  • Nintendo Stock Outlook: Profit Forecast And Switch Sales
  • Nancy Pelosi takes Hakeem Jeffries on tour of California’s high-class Democrat donors
  • Lawmakers introduce legislation holding UNRWA accountable for joining, assisting Hamas terror attack in Israel
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Gaza aid from US, others falling short as critics say better and cheaper ways: Nobody ‘knows what’s going on’
next post
American nonprofit tied to UNRWA sued by Oct. 7 survivors for ‘aiding and abetting’ Hamas terrorists

You may also like

Georgia Democrat calls out own party for opposing school choice,...

May 21, 2023

Hunter Biden tax charges dismissed by federal judge following plea...

August 18, 2023

Sen. Cotton wants to crack down on cybersecurity threats to...

January 26, 2024

Happy 2023: Adam and God

December 31, 2022

As Kamala gets coronated, Chicago gets democracy stress test

August 24, 2024

Burlington, Vermont, to vote on community police oversight board

March 7, 2023

Gen. Keane: China spy craft shows how serious Beijing is...

February 20, 2023

Comer and MTG confront DOJ on whether Hunter Biden violated...

September 9, 2023

The wheels are falling off the Harris-Walz vibe bus

September 4, 2024

Hunter Biden’s gun pouch had cocaine residue on it, prosecutors...

January 17, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • The V Reversal is Impressive, but is it Enough?

      May 9, 2025
    • Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

      May 8, 2025
    • Don’t Buy Robinhood Stock… Until You See This Chart Setup

      May 8, 2025
    • UnitedHealthcare sued by shareholders over reaction to CEO’s killing

      May 8, 2025
    • The Unpredictable Stock Market: How to Make Sense of It

      May 8, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,633 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,339 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,321 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,303 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,186 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,066)
    • Investing (538)
    • Stock (2,531)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • The V Reversal is Impressive, but is it Enough?

      May 9, 2025
    • Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout,...

      May 8, 2025
    • Don’t Buy Robinhood Stock… Until You See This Chart Setup

      May 8, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,066)
    • Investing (538)
    • Stock (2,531)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Where is the AI boom? Experts...

    January 18, 2024

    Democrats largely silent on anti-police violence...

    January 22, 2023

    Biden continues vacation for second straight...

    August 29, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here